Sort
30,917 grants matching “tumor microenvironment”
Site Specific Drug Delivery with Light-responsive Conjugates for Photo-biomodulation
$343,252Youngjae You · State University Of New York At Buffalo · R01 · FY2024 · GM
Improvement of cellular immunotherapy during dysbiosis- Resubmission
$343,184Ruud P.m. Dings · Univ Of Arkansas For Med Scis · R01 · FY2023 · CA
Improving glioma radiotherapy by theragnostic targeting of tumor-supporting macrophages
$343,172Matthew Scarpelli · Purdue University · R01 · FY2025 · NS
Project 1: Treatment of GBM using an oncolytic HSV engineered to improve immunogenic tumor destruction
$343,160Joseph C. Glorioso · Brigham And Women'S Hospital · P01 · FY2023 · CA
Exploiting dual-TCR for rescue of CD8 T cell tolerance in adoptive immunotherapy
$343,159Ryan M Teague · Saint Louis University · R01 · FY2013 · AI
Impact of microRNA processing on EMT of ovarian cancer cells
$343,140Shuang Huang · University Of Florida · R01 · FY2020 · CA
Label-Free, Longitudinal, Multi-Metric Viability Imaging of 3D Tissue Spheroid Array
$343,136Jonghwan Lee · Brown University · R01 · FY2023 · CA
TARGETING TRYPTOPHAN METABOLISM IN COLITIS ASSOCIATED CANCER
$343,125Matthew Aaron Ciorba · Washington University · R01 · FY2019 · DK
Functional proton-electron double-resonance imaging: development and application
$343,125Alexandre Valentin Samouilov · Ohio State University · R01 · FY2012 · EB
Profiling chemical tumor microenvironment: application for diagnostics & therapy
$343,125Valery V Khramtsov · West Virginia University · R01 · FY2018 · CA
TARGETING TRYPTOPHAN METABOLISM IN COLITIS ASSOCIATED CANCER
$343,125Matthew Aaron Ciorba · Washington University · R01 · FY2016 · DK
Integrative systems approach to identify local oncogenic modulation of the IL12 axis
$343,125David John Klinke · West Virginia University · R01 · FY2020 · CA
Profiling chemical tumor microenvironment: application for diagnostics & therapy
$343,125Valery V Khramtsov · West Virginia University · R01 · FY2017 · CA
TARGETING TRYPTOPHAN METABOLISM IN COLITIS ASSOCIATED CANCER
$343,125Matthew Aaron Ciorba · Washington University · R01 · FY2020 · DK
TARGETING TRYPTOPHAN METABOLISM IN COLITIS ASSOCIATED CANCER
$343,125Matthew Aaron Ciorba · Washington University · R01 · FY2017 · DK
Integrative systems approach to identify local oncogenic modulation of the IL12 axis
$343,125David John Klinke · West Virginia University · R01 · FY2017 · CA
Integrative systems approach to identify local oncogenic modulation of the IL12 axis
$343,125David John Klinke · West Virginia University · R01 · FY2018 · CA
MAPK pathway modulation in thyroid tumorigenesis
$343,125Aime T. Franco · Univ Of Arkansas For Med Scis · R01 · FY2018 · CA
Targeting CD44-mediated calcium signaling for the treatment of relapsed myeloma
$343,122Lori A Hazlehurst · West Virginia University · R01 · FY2015 · CA
Heat shock proteins in cancer and signaling
$343,115Michael Y Sherman · Boston University Medical Campus · R01 · FY2007 · CA
Heat shock proteins in cancer and signaling
$343,115Michael Y Sherman · Boston University Medical Campus · R01 · FY2008 · CA
Biomaterial Mimicry of Dynamic Matrix Stiffening During Tumor Progression
$343,103Adam J Engler · University Of California, San Diego · R01 · FY2020 · CA
Polymeric Nanomedicines of Small Molecules and miRNA for Treating Pancreatic Canc
$343,092Ram I Mahato · University Of Nebraska Medical Center · R01 · FY2014 · EB
Targeting EphB4-ephrinB2 to decrease immunosuppression in HNSCC
$343,092Sana D Karam · University Of Colorado Denver · P50 · FY2025 · CA
Targeting epigenetic heterogeneity to improve lung cancer immunotherapy response
$342,988Christine Fillmore Brainson · University Of Kentucky · R01 · FY2023 · CA